Lv6
1870 积分 2021-05-19 加入
Effects of nerandomilast, a preferential PDE4B inhibitor, on metabolism of midazolam, a sensitive CYP3A substrate
6小时前
求助中
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
3个月前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
3个月前
已完结
Interstitial Lung Disease
3个月前
已完结
Mechanisms and regulation of endothelial VEGF receptor signalling
4个月前
已完结
Biology and therapeutic targeting of vascular endothelial growth factor A
4个月前
已完结
Diabetic macular edema: Upcoming therapies
7个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
9个月前
已完结
Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration
10个月前
已完结
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
10个月前
已完结
Sensitivity of PET/MR images in liver metastases from colorectal carcinoma
皖公网安备34019202002308
